(125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma - Wikidata - wikimedia - TriplyDB

(125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma

(125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma

http://www.wikidata.org/entity/Q24658608

about

Construction of a human monoclonal antibody against bFGF for suppression of NSCLC.

P2860

Q55473120-0445023B-85EB-44EC-B44E-2E9A46628921

P2860

(125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma

http://www.wikidata.org/entity/Q24658608

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

(125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma

@ast

(125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma

@en

(125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma

@nl

type

label

(125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma

@ast

(125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma

@en

(125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma

@nl

prefLabel

(125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma

@ast

(125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma

@en

(125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma

@nl

P1433

Q24658608-24BD9656-5F89-40A0-9866-5673B7DC7576

P1476

Q24658608-D07D7258-5B11-4DC7-9D05-254796EBB0CD

P2093

Q24658608-084BE23E-7AF0-445A-9334-DEB1DE01DFD7

Q24658608-65E0A282-983A-437C-B41D-E8E517DF7C6E

Q24658608-6DD80C05-F845-4759-AAB6-F254CC1A1533

Q24658608-90C6F275-8612-4129-8B10-9A81C55344C7

Q24658608-9DF0A084-CDB0-4395-90E8-21B822D384C6

Q24658608-CB189715-288E-4213-B872-4238D305347C

Q24658608-EFB104AE-BA9C-4C32-89D5-BBAC6970AED3

Q24658608-FD07138C-1DF3-465D-9013-3C912424711E

P2860

Q24658608-003B0A72-0ECF-49AA-A395-2EC0B6380D43

Q24658608-05C35D90-3B0A-41DD-BA4B-DC3ADEAEBEA0

Q24658608-0BFCEBF2-6374-4E26-8498-DE1F440643F7

Q24658608-10FA834B-BE00-42C8-B165-9BD7710179E6

Q24658608-12B6D23C-AB33-47E9-913B-9C254797FAB5

Q24658608-3570DB9D-95FF-4C4C-B411-3F4E35DD803D

Q24658608-49F39433-A905-4746-A74B-28BA07B9187E

Q24658608-5EEB6BC0-DB52-4E8C-92EE-E1BB5E48EBC2

Q24658608-5F8C37B9-DF64-4973-962B-3E12D7A6EA04

Q24658608-63B349C5-E1D7-4923-8E43-AC4ADB11F739

P304

Q24658608-D9C99C23-ABF1-4604-A4BD-18F9579E6C27

P31

Q24658608-31C225F1-FC3A-4F72-8F69-2C2D9D23AB7B

P356

Q24658608-6DFF019E-9F90-4DFF-81CD-B615F0FFA1E3

P407

Q24658608-E78FA742-C28A-416C-B17C-E2E3E4038B8C

P433

Q24658608-B422465F-979D-47F6-BD0D-D900B3A9FB21

P478

Q24658608-828EE02B-BFB9-4E0A-AE4F-BCD11492B633

P577

Q24658608-C32E08F3-6679-4227-8E22-AE65AD56A630

P698

Q24658608-F3359120-2087-484D-B85E-7B664C89C209

P932

Q24658608-C30E1536-5180-40B9-92C2-DF144096F0A1

P356

WJG.V22.I21.5033

P1433

World Journal of Gastroenterology

P1476

(125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma

@en

P2093

Hong Wang

http://www.w3.org/2001/XMLSchema#string

Jun-Jian Xiang

http://www.w3.org/2001/XMLSchema#string

Lan-Hong Pan

http://www.w3.org/2001/XMLSchema#string

Meng Xu

http://www.w3.org/2001/XMLSchema#string

Patrick Ting-Yat Wong

http://www.w3.org/2001/XMLSchema#string

Peng-Hui Hu

http://www.w3.org/2001/XMLSchema#string

Wen-Hui Chen

http://www.w3.org/2001/XMLSchema#string

Yan-Qing Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors

Hepatocellular carcinoma

Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation.

Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model

Biomarkers for antitumor activity of bevacizumab in gastric cancer models.

Overexpression of platelet-derived growth factor receptor alpha promotes tumor progression and indicates poor prognosis in hepatocellular carcinoma

Outcome of transarterial chemoembolization-based multi-modal treatment in patients with unresectable hepatocellular carcinoma

Complete remission of advanced hepatocellular carcinoma by radiofrequency ablation after sorafenib therapy.

Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma.

Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4.

P304

5033-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V22.I21.5033

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27275095

http://www.w3.org/2001/XMLSchema#string

P932

4886378

http://www.w3.org/2001/XMLSchema#string